semaglutide and depression GLP-1s linked to lower rates of anxiety than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Semaglutide for the treatment of

Notably, one-third of the patients in this study achieved clinically meaningful weight loss, defined as a reduction of at least 5% of their body weight

The GI consequences are severe

Spare: Vitamin C takes the first hit from free radicals, saving glutathione for deeper cellular work

Among adolescents aged 1217 years with obesity, prescription use increased from 0.1 percent in 2020 to 0.5 percent in 2023, representing a relative rise of more than 300 percent, although total usage remains below 1 percent

Cataract Risk Factors Factors that increase your chances of developing cataracts include: smoking tobacco too much alcohol obesity genetics high blood pressure certain drugs, including steroids blood sugar imbalances, whether diagnosed as diabetes or not excessive sunlight physical trauma (injury, such as blunt trauma) chemical exposure poor diet lack of exercise poor absorption/digestive issues autoimmune disease As you age, risk factors pile up

Other listings under the HorseFil name do make such claims, but thats not confirmed here